E-LIB Suche - Ergebnisse für: Chiu, Chao-Hua

1

Updated efficacy and safety of entrectinib in NTRK fusion-p..:

Cho, Byoung Chul ; Chiu, Chao-Hua ; Massarelli, Erminia...
Lung Cancer. 188 (2024) - p. 107442 , 2024

Link: https://doi.org/10.1016/..

2

Trouble with promoting lung cancer screening in never-smoke..:

Chiu, Chao-Hua ; Yu, Chong-Jen ; Chang, Gee-Chen.
The Lancet Respiratory Medicine. 12 (2024) 4 - p. e15 , 2024

Link: https://doi.org/10.1016/..

3

Low-dose CT screening among never-smokers with or without a..:

Chang, Gee-Chen ; Chiu, Chao-Hua ; Yu, Chong-Jen...
The Lancet Respiratory Medicine. 12 (2024) 2 - p. 141-152 , 2024

Link: https://doi.org/10.1016/..

4

Brief Report: Updated Efficacy and Safety Data From an Inte..:

Fan, Yun ; Drilon, Alexander ; Chiu, Chao-Hua...
Clinical Lung Cancer. 25 (2024) 2 - p. e81-e86.e4 , 2024

Link: https://doi.org/10.1016/..

5

Durvalumab in combination with chemoradiotherapy for patien..:

Kim, Dong-Wan ; Chul Cho, Byoung ; Pachipala, Krishna...
Lung Cancer. 190 (2024) - p. 107530 , 2024

Link: https://doi.org/10.1016/..

6

Entrectinib in ROS1-positive advanced non-small cell lung c..:

Peters, Solange ; Gadgeel, Shirish M. ; Mok, Tony...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

7

Evaluation of combination treatment with DS-1205c, an AXL k..:

Yang, James Chih-Hsin ; Su, Wu-Chou ; Chiu, Chao-Hua...
Investigational New Drugs. 41 (2023) 2 - p. 306-316 , 2023

Link: https://doi.org/10.1007/..

8

Efficacy and Tolerability of Ramucirumab Plus Erlotinib in ..:

Chiu, Chao-Hua ; Lin, Meng-Chih ; Wei, Yu-Feng...
Targeted Oncology. 18 (2023) 4 - p. 505-515 , 2023

Link: https://doi.org/10.1007/..

9

Never Say No to Never-Smokers:

Chiu, Chao-Hua ; Yang, Pan-Chyr
Journal of Thoracic Oncology. 18 (2023) 6 - p. 689-693 , 2023

Link: https://doi.org/10.1016/..

10

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Stu..:

Zhou, Qing ; Soo, Ross A. ; Chang, Gee-Chen...
JTO Clinical and Research Reports. 4 (2023) 5 - p. 100499 , 2023

Link: https://doi.org/10.1016/..

11

Proliferative ability of circulating tumor cells is a progn..:

Che, Ting-Fang ; Chiu, Chao-Hua ; Wu, Yu-Chung...
Lung Cancer. 178 (2023) - p. 198-205 , 2023

Link: https://doi.org/10.1016/..

12

Early Circulating Tumor DNA Dynamics and Efficacy of Lorlat..:

Soo, Ross A. ; Martini, Jean-François ; van der Wekken, Anthonie J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. 1568-1580 , 2023

Link: https://doi.org/10.1016/..

13

Prognosticators of osimertinib treatment outcomes in patien..:

Chiang, Chi-Lu ; Ho, Hsiang-Ling ; Yeh, Yi-Chen...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 1 - p. 5-14 , 2022

Link: https://doi.org/10.1007/..

14

Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion..:

Drilon, Alexander ; Chiu, Chao-Hua ; Fan, Yun...
JTO Clinical and Research Reports. 3 (2022) 6 - p. 100332 , 2022

Link: https://doi.org/10.1016/..

15

Efficacy of Aumolertinib (HS-10296) in Patients With Advanc..:

Lu, Shun ; Wang, Qiming ; Zhang, Guojun...
Journal of Thoracic Oncology. 17 (2022) 3 - p. 411-422 , 2022

Link: https://doi.org/10.1016/..